The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, reminiscent of semaglutide (Ozempic and Wegovy) is a breakthrough within the administration of weight problems. These drugs have confirmed to be very efficient in selling weight reduction and bettering blood sugar ranges.
Whereas lots of people might imagine that I’ve one thing towards GLP-1s – whether or not as a result of they’re ‘competitors’ for my apply (they aren’t), or that possibly I don’t agree with utilizing prescription drugs over food regimen for weight reduction. I wrote all about that right here.
I consider the brand new class of weight reduction drugs are unimaginable instruments that can assist to vary folks’s lives for the higher. However they aren’t the whole puzzle; they’re solely only a piece, and there are some very actual limitations to their use.
Current analysis suggests that weight problems charges within the US have dropped very barely – from 46% in 2022 to 45.6% in 2023. There was a 700% enhance in the usage of GLP-1 agonist drugs between 2019 and 2023.
Though even a 0.04% change in weight problems charges could point out a common downward development which may be attributed partially to GLP-1 drugs, there are good causes to consider that these medicine won’t drastically cut back the prevalence of weight problems…not less than, not now. However why?
The reply to this query is multifaceted and complex.
Limitations of GLP-1 Medicines in Addressing Inhabitants-Vast Epidemic
Value and Accessibility: These drugs are tremendous costly – as in, over $15,000 a 12 months in some instances. This can be a large barrier for individuals who can’t afford to pay out of pocket, or who don’t have personal insurance coverage protection. Even for these with personal insurance coverage, firms typically cap spending or length for GLP-1 drugs. Whereas some folks qualify for GLP-1 meds by Medicare or Medicaid, many don’t.
A latest listening to of the US Senate Committee on Well being, Training, Labor, and Pensions revealed that Ozempic prices 15x extra in the US than in Germany. Knowledge on affected person discontinuation of GLP-1 receptor agonist drugs is inconclusive, however numbers vary from round 50% inside 3 months to 75% by the two 12 months mark. The explanations for going off the meds embody price, unintended effects, or sluggish weight reduction.
In different phrases, so many individuals who would doubtless profit significantly from these drugs, simply can’t entry them in any respect, or for lengthy sufficient. Entry is decrease for folks in sure racial and ethnic teams, that are additionally the teams which have the best charges of weight problems (and the bottom entry to healthcare total).
The patents for a number of of those drugs are up in March, 2026, which means that cheaper generic variations of semaglutide will doubtless be available on the market shortly after that. Will they be far more inexpensive? Solely time will inform.
Sustainability of Results: Whereas GLP-1 drugs are efficient for weight reduction, analysis means that these drugs are in all probability a long-term dedication. For many individuals, their advantages are contingent on continued use. A examine from the STEP 1 trial highlighted that two-thirds of the load misplaced utilizing semaglutide was regained inside a 12 months after remedy discontinuation. Because the numbers point out, some weight regain is probably going, however that’s not essentially true for everybody.
After I work with shoppers who’re on GLP-1 agonist drugs, we focus not solely on meals, but in addition on relationship with meals and with life-style adjustments reminiscent of growing bodily exercise.
Limitations on Efficacy of GLP-1 Agonist Medicines: In line with Dr. Spencer Nadolsky, D.O. and Weight problems and Lipid Specialist, these meds do have their limits.
Proper now, the typical is round 20% weight reduction with Tizepatide (Mounjaro). For a 400 pound particular person, that will imply 80 kilos misplaced. That particular person nonetheless has weight problems.
Along with this, Dr. Nadolsky strengthened the truth that not everybody responds to those drugs.
Root Causes of Weight problems: Weight problems is pushed by complicated components, together with socioeconomic disparities, meals system points, and sedentary life. Conversely, GLP-1 drugs primarily goal processes reminiscent of urge for food regulation and insulin sensitivity. These are clearly necessary, however to essentially impact change on weight problems charges, there must be a complete focus not solely on pharmacology, but in addition public well being interventions. A 2023 evaluate in Nature Medication proposed that initiatives to deal with this problem which have 4 components: informing the general public about diet, enabling them to make health-promoting decisions, motivating them to make adjustments to their routines and habits, and influencing behaviour by way of social norms and different strategies.
The evaluate instructed growing lively transport, growing healthcare payor incentives, bettering entry to and affordability of wholesome meals, limiting availability and media advertising of high-calorie meals, bettering meals labeling, reformulating meals merchandise to be extra healthful, and growing entry to weight administration applications and bariatric surgical procedure.
Aspect Results and Contraindications: Widespread unintended effects of GLP-1 drugs, reminiscent of nausea, vomiting, and gastrointestinal discomfort, can deter adherence. Moreover, these medicine are contraindicated for people with sure circumstances, reminiscent of kidney illness, sure cancers, and a historical past of pancreatitis.
The Position of Dietary Interventions
GLP-1 drugs are efficient for most individuals, however adjustments in food regimen do have to be a part of their use. Dietary methods can improve the efficacy of remedy whereas supporting long-term well being.
Listed here are some suggestions for consuming whereas on a GLP-1 drugs:
Prioritize Protein and Fiber: GLP-1 drugs sluggish gastric emptying, selling early satiety. Because of this most meals and snacks must be nutrient-dense to keep away from nutrient deficiencies and promote total well being. A food regimen wealthy in lean proteins (e.g., meat and fish, tofu, eggs, Greek yogurt and ricotta, beans and lentils) helps to keep up muscle mass. Getting ~25+ grams of fiber per day from greens, entire grains, and fruits, helps maintain fullness and helps blood sugar management. Don’t sleep on beans or soy meals as a approach to get high-quality protein and fibre in a single place!
Decrease Extremely-Processed Meals: Processed meals excessive in refined carbohydrates, added sugars, and unhealthy fat can counteract the advantages of GLP-1 drugs. I like to recommend specializing in entire, minimally processed meals to enhance total metabolic well being. That additionally means minimizing alcohol and different lower-quality meals to assist maximize vitamins in your food regimen.
Hydration and Small, Frequent Meals: Folks on GLP-1 drugs typically expertise nausea, which could be mitigated by staying hydrated and consuming smaller, extra frequent meals. On nauseous days, incorporating meals which can be mild on the abdomen, reminiscent of soups and smoothies, can assist.
Conscious Consuming Practices: GLP-1 drugs cut back urge for food, creating a possibility to apply conscious consuming. Slowing down throughout meals, savoring meals, and listening to starvation cues can assist reinforce wholesome consuming behaviors.
Rising Weight Loss Medicines
Along with current GLP-1 receptor agonists, a number of promising weight reduction drugs are beneath improvement or awaiting approval:
- Orforglipron Eli Lilly is creating Orforglipron, an oral GLP-1 receptor agonist. This remedy might present an alternate for sufferers preferring to not use injectables.
- CagriSema (Cagrilintide/Semaglutide Mixture) Novo Nordisk is advancing this mix remedy, exhibiting vital weight reduction results in early trials.
- Retatrutide Retatrutide is a triple-hormone receptor agonist, with early research reporting substantial weight discount.
- VK2735 Viking Therapeutics is exploring VK2735, an oral remedy with promising preliminary outcomes.
Conclusion
GLP-1 drugs supply vital advantages for people fighting weight problems, however they don’t seem to be a panacea for the broader epidemics. Addressing these complicated, multifactorial challenges requires a complete method that mixes medical innovation with strong public well being efforts. By integrating dietary methods, selling equitable entry to care, and tackling systemic points, we are able to make significant progress towards reversing the developments in weight problems.
Are you searching for assist along with your diet? I’m taking new shoppers in my 1:1 apply. Get extra info and e book a session right here.
Do you know? I even have an internet course for diet in perimenopause and menopause known as Don’t Sweat It. Get extra info and join right here.
